Literature DB >> 19642137

Proliferative alloresponse of T-cytotoxic cells identifies rejection-prone children with steroid-free liver transplantation.

Chethan Ashokkumar1, Qing Sun, Ankit Gupta, Brandon W Higgs, Tamara Fazzolare, Lisa Remaley, George Mazariegos, Kyle Soltys, Geoffrey Bond, Rakesh Sindhi.   

Abstract

Donor-induced and third-party-induced proliferation of T-helper and T-cytotoxic (Tc) cells and their naïve and memory subsets was evaluated simultaneously in single blood samples from 77 children who received steroid-free liver transplantation (LTx) after induction with rabbit anti-human thymocyte globulin. Proliferation was measured by dilution of the intravital dye carboxyfluorescein succinimidyl ester (CFSE) in a 3- to 4-day mixed lymphocyte response coculture. The ratio of donor/third-party-induced proliferated (CFSE(low)) T-cells was reported as the immunoreactivity index (IR) for each subset. Rejectors were defined as those who experienced biopsy-proven acute cellular rejection within 60 days of the assay. IR > 1 signified increased risk of rejection, and IR < 1 implied decreased risk. Demographics for 32 rejectors and 45 nonrejectors were similar. Proliferated CFSE(low) T-cells and subsets were significantly higher among rejectors compared with nonrejectors. In 33 of 77 randomly selected children, logistic regression, leave-one-out cross-validation, and receiver operating characteristic analyses showed that the IR of Tc cells was best associated with biopsy-proven rejection (sensitivity > 75%, specificity > 88%). Sensitivity and specificity were replicated in the remaining 44 children who composed the validation cohort. IR of CFSE(low) Tc cells correlated significantly with IR of proinflammatory, allospecific CD154+ Tc cells (r = 0.664, P = 0.0005) and inversely with IR of allospecific, anti-inflammatory, cytotoxic T lymphocyte antigen 4-positive Tc cells (r = -0.630, P = 0.007). In conclusion, proliferative alloresponses of Tc cells can identify rejection-prone children receiving LTx. Liver Transpl 15:978-985, 2009. (c) 2009 AASLD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19642137      PMCID: PMC2997467          DOI: 10.1002/lt.21775

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  16 in total

1.  Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question.

Authors:  E J Suchin; P B Langmuir; E Palmer; M H Sayegh; A D Wells; L A Turka
Journal:  J Immunol       Date:  2001-01-15       Impact factor: 5.422

2.  Validation of logistic regression models in small samples: application to calvarial lesions diagnosis.

Authors:  D Bautista; E Arana; L Martí-Bonmatí; R Paredes
Journal:  J Clin Epidemiol       Date:  1999-03       Impact factor: 6.437

3.  Detection of alloreactive T cells by flow cytometry: a new test compared with limiting dilution assay.

Authors:  Aalzen De Haan; Ieneke Van Der Gun; Wim Van Der Bij; Lou F M H De Leij; Jochum Prop
Journal:  Transplantation       Date:  2002-08-27       Impact factor: 4.939

4.  Multiparameter flow cytometric approach for simultaneous evaluation of proliferation and cytokine-secreting activity in T cells responding to allo-stimulation.

Authors:  Yuka Tanaka; Hideki Ohdan; Takashi Onoe; Toshimasa Asahara
Journal:  Immunol Invest       Date:  2004-08       Impact factor: 3.657

5.  Determination of lymphocyte division by flow cytometry.

Authors:  A B Lyons; C R Parish
Journal:  J Immunol Methods       Date:  1994-05-02       Impact factor: 2.303

6.  Pretransplant frequency of donor-specific, IFN-gamma-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes.

Authors:  P S Heeger; N S Greenspan; S Kuhlenschmidt; C Dejelo; D E Hricik; J A Schulak; M Tary-Lehmann
Journal:  J Immunol       Date:  1999-08-15       Impact factor: 5.422

7.  Enhanced donor-specific alloreactivity occurs independently of immunosuppression in children with early liver rejection.

Authors:  Rakesh Sindhi; Amy Magill; Carol Bentlejewski; Ali Abdullah; Mary Tresgaskes; Joseph Seward; Janine Janosky; Adriana Zeevi
Journal:  Am J Transplant       Date:  2005-01       Impact factor: 8.086

8.  Studies of Pediatric Liver Transplantation 2002: patient and graft survival and rejection in pediatric recipients of a first liver transplant in the United States and Canada.

Authors:  S R Martin; P Atkison; R Anand; A S Lindblad
Journal:  Pediatr Transplant       Date:  2004-06

9.  Functional assessment and specific depletion of alloreactive human T cells using flow cytometry.

Authors:  Sergio L R Martins; Lisa S St John; Richard E Champlin; Eric D Wieder; John McMannis; Jeffrey J Molldrem; Krishna V Komanduri
Journal:  Blood       Date:  2004-07-29       Impact factor: 22.113

10.  Allospecific CD154+ T cells associate with rejection risk after pediatric liver transplantation.

Authors:  C Ashokkumar; A Talukdar; Q Sun; B W Higgs; J Janosky; P Wilson; G Mazariegos; R Jaffe; A Demetris; J Dobberstein; K Soltys; G Bond; A W Thomson; A Zeevi; R Sindhi
Journal:  Am J Transplant       Date:  2008-10-31       Impact factor: 8.086

View more
  1 in total

1.  Lymphocyte activation markers may predict the presence of donor specific alloreactivity in pediatric living related liver transplant recipients.

Authors:  Udeme D Ekong; Xunrong Luo; Min Yu; Delli Wang; Stephen D Miller; Maurice R G O'Gorman
Journal:  Hum Immunol       Date:  2011-02-26       Impact factor: 2.850

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.